Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7515 |
Intermediate Similarity |
NPD2457 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD2456 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD2136 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2134 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2135 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD1016 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1015 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1333 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD8861 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8862 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8859 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD174 |
Discontinued |
0.6897 |
Remote Similarity |
NPD1895 |
Discontinued |
0.68 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6742 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD207 |
Discontinued |
0.6648 |
Remote Similarity |
NPD645 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.6646 |
Remote Similarity |
NPD2618 |
Phase 1 |
0.6632 |
Remote Similarity |
NPD1506 |
Discontinued |
0.6611 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.661 |
Remote Similarity |
NPD3593 |
Approved |
0.66 |
Remote Similarity |
NPD300 |
Approved |
0.6597 |
Remote Similarity |
NPD2443 |
Approved |
0.6597 |
Remote Similarity |
NPD2442 |
Approved |
0.6597 |
Remote Similarity |
NPD9132 |
Discontinued |
0.6595 |
Remote Similarity |
NPD2880 |
Discontinued |
0.6593 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6591 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.659 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD9724 |
Phase 1 |
0.6579 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6561 |
Remote Similarity |
NPD2364 |
Suspended |
0.6556 |
Remote Similarity |
NPD5757 |
Discontinued |
0.655 |
Remote Similarity |
NPD1313 |
Approved |
0.6545 |
Remote Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.6541 |
Remote Similarity |
NPD2316 |
Clinical (unspecified phase) |
0.6506 |
Remote Similarity |
NPD2180 |
Approved |
0.6505 |
Remote Similarity |
NPD1174 |
Phase 2 |
0.6492 |
Remote Similarity |
NPD2008 |
Discontinued |
0.6474 |
Remote Similarity |
NPD2333 |
Discontinued |
0.6467 |
Remote Similarity |
NPD5974 |
Approved |
0.6467 |
Remote Similarity |
NPD5973 |
Phase 2 |
0.6464 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.646 |
Remote Similarity |
NPD9627 |
Approved |
0.6443 |
Remote Similarity |
NPD306 |
Approved |
0.6437 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6433 |
Remote Similarity |
NPD418 |
Approved |
0.6432 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD2604 |
Approved |
0.6425 |
Remote Similarity |
NPD1708 |
Approved |
0.6425 |
Remote Similarity |
NPD1707 |
Approved |
0.6416 |
Remote Similarity |
NPD1215 |
Discontinued |
0.6414 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.6414 |
Remote Similarity |
NPD8257 |
Approved |
0.6414 |
Remote Similarity |
NPD8256 |
Approved |
0.6407 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.6393 |
Remote Similarity |
NPD1250 |
Clinical (unspecified phase) |
0.6392 |
Remote Similarity |
NPD2408 |
Discontinued |
0.6389 |
Remote Similarity |
NPD1332 |
Clinical (unspecified phase) |
0.6374 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.6369 |
Remote Similarity |
NPD809 |
Discontinued |
0.6369 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.6368 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6368 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6364 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6353 |
Remote Similarity |
NPD1869 |
Phase 2 |
0.6353 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.6344 |
Remote Similarity |
NPD2445 |
Approved |
0.6344 |
Remote Similarity |
NPD2446 |
Approved |
0.6333 |
Remote Similarity |
NPD412 |
Approved |
0.6329 |
Remote Similarity |
NPD9628 |
Approved |
0.6322 |
Remote Similarity |
NPD2392 |
Clinical (unspecified phase) |
0.631 |
Remote Similarity |
NPD2660 |
Approved |
0.631 |
Remote Similarity |
NPD2662 |
Approved |
0.6308 |
Remote Similarity |
NPD1600 |
Suspended |
0.63 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.63 |
Remote Similarity |
NPD3521 |
Phase 2 |
0.6299 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6296 |
Remote Similarity |
NPD1982 |
Phase 1 |
0.6296 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.6294 |
Remote Similarity |
NPD2411 |
Approved |
0.6294 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6294 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.6289 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6286 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.6283 |
Remote Similarity |
NPD3831 |
Approved |
0.6279 |
Remote Similarity |
NPD3130 |
Discontinued |
0.6279 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6272 |
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |
0.6271 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.627 |
Remote Similarity |
NPD5685 |
Approved |
0.627 |
Remote Similarity |
NPD5686 |
Approved |
0.6266 |
Remote Similarity |
NPD803 |
Phase 1 |
0.6263 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.6257 |
Remote Similarity |
NPD460 |
Discontinued |
0.6257 |
Remote Similarity |
NPD2931 |
Phase 1 |
0.625 |
Remote Similarity |
NPD1027 |
Approved |
0.625 |
Remote Similarity |
NPD1030 |
Approved |
0.625 |
Remote Similarity |
NPD9598 |
Discontinued |
0.625 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.6241 |
Remote Similarity |
NPD8836 |
Approved |
0.6237 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.6232 |
Remote Similarity |
NPD9194 |
Approved |
0.6232 |
Remote Similarity |
NPD9193 |
Approved |
0.623 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.6211 |
Remote Similarity |
NPD7459 |
Phase 2 |
0.6205 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6203 |
Remote Similarity |
NPD2839 |
Phase 2 |
0.6201 |
Remote Similarity |
NPD2864 |
Phase 1 |
0.6196 |
Remote Similarity |
NPD706 |
Phase 1 |
0.6196 |
Remote Similarity |
NPD2872 |
Phase 2 |
0.619 |
Remote Similarity |
NPD6278 |
Clinical (unspecified phase) |
0.6188 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.6176 |
Remote Similarity |
NPD695 |
Discontinued |
0.6176 |
Remote Similarity |
NPD491 |
Approved |
0.6176 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.6173 |
Remote Similarity |
NPD2026 |
Approved |
0.6171 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6169 |
Remote Similarity |
NPD5465 |
Phase 2 |
0.6167 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6166 |
Remote Similarity |
NPD6269 |
Clinical (unspecified phase) |
0.6166 |
Remote Similarity |
NPD6268 |
Phase 1 |
0.6162 |
Remote Similarity |
NPD4863 |
Approved |
0.6158 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.6158 |
Remote Similarity |
NPD5884 |
Clinical (unspecified phase) |
0.6158 |
Remote Similarity |
NPD5446 |
Phase 2 |
0.6158 |
Remote Similarity |
NPD5462 |
Discontinued |
0.615 |
Remote Similarity |
NPD4395 |
Phase 1 |
0.6144 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.6144 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.6144 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.6136 |
Remote Similarity |
NPD439 |
Approved |
0.6136 |
Remote Similarity |
NPD438 |
Approved |
0.6135 |
Remote Similarity |
NPD1451 |
Approved |
0.6133 |
Remote Similarity |
NPD1327 |
Discontinued |
0.6129 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6125 |
Remote Similarity |
NPD9133 |
Approved |
0.6122 |
Remote Similarity |
NPD796 |
Phase 2 |
0.612 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.6117 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6117 |
Remote Similarity |
NPD2127 |
Suspended |
0.6117 |
Remote Similarity |
NPD3430 |
Approved |
0.6117 |
Remote Similarity |
NPD3431 |
Approved |
0.6108 |
Remote Similarity |
NPD4902 |
Discontinued |
0.6108 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6105 |
Remote Similarity |
NPD1290 |
Phase 2 |
0.6105 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.6105 |
Remote Similarity |
NPD2960 |
Clinical (unspecified phase) |
0.6105 |
Remote Similarity |
NPD939 |
Clinical (unspecified phase) |
0.6096 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.6095 |
Remote Similarity |
NPD426 |
Approved |
0.6095 |
Remote Similarity |
NPD428 |
Approved |
0.6095 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6095 |
Remote Similarity |
NPD162 |
Approved |
0.6095 |
Remote Similarity |
NPD427 |
Approved |
0.6085 |
Remote Similarity |
NPD6265 |
Discontinued |
0.6078 |
Remote Similarity |
NPD245 |
Suspended |
0.6076 |
Remote Similarity |
NPD1031 |
Discontinued |
0.6075 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6068 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6068 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6064 |
Remote Similarity |
NPD2892 |
Phase 1 |
0.6062 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.6061 |
Remote Similarity |
NPD2222 |
Discontinued |
0.6059 |
Remote Similarity |
NPD703 |
Discontinued |
0.6056 |
Remote Similarity |
NPD2829 |
Clinical (unspecified phase) |
0.6053 |
Remote Similarity |
NPD420 |
Discontinued |
0.6048 |
Remote Similarity |
NPD8317 |
Phase 2 |
0.6048 |
Remote Similarity |
NPD8316 |
Phase 2 |
0.6042 |
Remote Similarity |
NPD1249 |
Clinical (unspecified phase) |
0.6034 |
Remote Similarity |
NPD3105 |
Discontinued |
0.6025 |
Remote Similarity |
NPD2602 |
Clinical (unspecified phase) |
0.6022 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.6011 |
Remote Similarity |
NPD2818 |
Discontinued |
0.601 |
Remote Similarity |
NPD6264 |
Discontinued |
0.6 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD2362 |
Approved |
0.5989 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.5989 |
Remote Similarity |
NPD5013 |
Approved |
0.598 |
Remote Similarity |
NPD2819 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5978 |
Remote Similarity |
NPD4024 |
Phase 3 |
0.5978 |
Remote Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.5977 |
Remote Similarity |
NPD8504 |
Discovery |
0.5974 |
Remote Similarity |
NPD1734 |
Clinical (unspecified phase) |
0.597 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.5967 |
Remote Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.5967 |
Remote Similarity |
NPD2928 |
Phase 2 |
0.5965 |
Remote Similarity |
NPD971 |
Clinical (unspecified phase) |
0.5962 |
Remote Similarity |
NPD6465 |
Phase 2 |
0.5959
|
Remote Similarity |
NPD3287 |
Clinical (unspecified phase) |